Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Stanford University
BioEclipse Therapeutics